JB CHEMICALS & PHARMACEUTICALS LTD.

NSE : JBCHEPHARMBSE : 506943ISIN CODE : INE572A01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE1117.25-21.7 (-1.91 %)

PREV CLOSE (Rs.) 1138.95

OPEN PRICE (Rs.) 1138.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 18565

TODAY'S LOW / HIGH (Rs.)1106.60 1205.00

52 WK LOW / HIGH (Rs.)434.9 1262.95

NSE1118.60-19.85 (-1.74 %)

PREV CLOSE( Rs. ) 1138.45

OPEN PRICE (Rs.) 1130.00

BID PRICE (QTY) 1118.60 (33)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 239015

TODAY'S LOW / HIGH(Rs.) 1107.05 1206.30

52 WK LOW / HIGH (Rs.)415 1263

More From Company Profile

Cash Flow

Select year

Particulars	Mar2020	Mar2019	Mar2018	Mar2017	Mar2016
Profit Before Tax	3488.92	2869.93	1939.51	2299.44	2122.31
Adjustment	79.55	237.20	169.12	131.06	-13.95
Changes In working Capital	93.24	-514.72	-470.75	59.17	-169.57
Cash Flow after changes in Working Capital	3661.71	2592.41	1637.88	2489.66	1938.79
Cash Flow from Operating Activities	2753.72	1943.26	1229.21	2011.29	1404.06
Cash Flow from Investing Activities	243.03	-276.65	-206.82	-453.10	-276.22
Cash Flow from Financing Activities	-3060.51	-1557.38	-595.23	-1838.36	-996.18
Net Cash Inflow / Outflow	-63.77	109.22	427.16	-280.16	131.66
Opening Cash & Cash Equivalents	321.42	212.43	-214.73	65.43	-54.57
Cash & Cash Equivalent on Amalgamation / Take over / Merger	NA	NA	NA	NA	17.15
Cash & Cash Equivalent of Subsidiaries under liquidations	NA	NA	NA	NA	NA
Translation adjustment on reserves / op cash balalces frgn subsidiaries	NA	NA	NA	NA	NA
Effect of Foreign Exchange Fluctuations	-0.13	-0.23	NA	NA	NA
Closing Cash & Cash Equivalent	257.52	321.42	212.43	-214.73	94.24

ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING

Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.

CORPORATE OFFICE

address

9/2003-4,
Vishnu Priya Limda Chowk
Main Road
Surat – 395 003.

call us @ +91-261-6673500 +91-261-2436536

fax us @ +91-261-6673537

email us @ info@rwadiwala.com

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage.

JB CHEMICALS & PHARMACEUTICALS LTD.

Cash Flow

Filing complaints on SCORES Easy & quick